Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors von YAP, Timothy A, VIDAL, Laura, UTTENREUTHER-FISCHER, Martina, STOPFER, Peter, FUTREAL, Andrew, CALVERT, Hilary, DE BONO, Johann S, PLUMMER, Ruth, ADAM, Jan, STEPHENS, Peter, SPICER, James, SHAW, Heather, ANG, Jooern, TEMPLE, Graham, BELL, Susan, SHAHIDI, Mehdi

Volltext

Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer von Tan, David S.P, Yap, Timothy A, Hutka, Margaret, Roxburgh, Patricia, Ang, Jooern, Banerjee, Susana, Grzybowska, Ewa, Gourley, Charlie, Gore, Martin E, Kaye, Stan B

Volltext